Helico is based and supported by the deep-tech incubator Outset Ventures in Parnell, Auckland – NZ.

Source: The Spinoff NZ, April 2021

Zoom on Helico vision

HelicoBio is looking to generate compounds for drug development through turning plants into factories.

Source: Knook NZ, October 2021

Helico research is supported by Callaghan Innovation, New Zealand innovation agency.

Helico is aiming to produce therapeutic compounds from plantsand, ultimately, ‘edible medicine’, with insulin its first target.

Source: Callaghan Innovation, November 2021

Helico, is part of 'the sectors where New Zealand startups are poised to win'

Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas in New Zealand that international investors say they’re either actively investing in or watching for signs of scale.

Source: Techcrunch US, December 2021

Austrian billionaire backs Kiwi biopharma startup

Helico is designing plants to manufacture life-saving medicines.

Source: www.nbr.co.nz